Peters R W, Kim H J, Buser G A, Gold M R
Department of Medicine, Baltimore Veterans Administration Medical Center.
Chest. 1993 Nov;104(5):1613-4. doi: 10.1378/chest.104.5.1613.
We describe a patient with ischemically mediated sustained monomorphic ventricular tachycardia occurring at rest and resistant to treatment with intravenously administered procainamide. Percutaneous transluminal coronary angioplasty was initially successful, but rest angina and ventricular tachycardia, resistant to procainamide therapy, recurred 2 weeks later and responded to aggressive anti-ischemic medical therapy. We suggest that anti-ischemic medication may be of benefit in patients with malignant ventricular arrhythmias precipitated by spontaneous myocardial ischemia.
我们描述了一名患者，其在静息状态下出现由缺血介导的持续性单形性室性心动过速，且对静脉注射普鲁卡因胺治疗耐药。经皮腔内冠状动脉成形术最初取得成功，但2周后静息性心绞痛和对普鲁卡因胺治疗耐药的室性心动过速复发，对积极的抗缺血药物治疗有反应。我们认为，抗缺血药物可能对由自发性心肌缺血引发的恶性室性心律失常患者有益。
